SynthesisMedicine2026

Beneficial subgroups for PD-1 inhibitor plus chemotherapy in first-line treatment of advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis.

Rui Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.